Jazz Pharmaceuticals (JAZZ): Q1 EPS of $0.59 beats by $0.02. Revenue of $51M (+45% Y/Y) in-line....

|About: Jazz Pharmaceuticals, Inc. (JAZZ)|By:, SA News Editor
Jazz Pharmaceuticals (JAZZ): Q1 EPS of $0.59 beats by $0.02. Revenue of $51M (+45% Y/Y) in-line. Shares -0.38% AH. (PR)